The Era of AI Healthcare: Challenges in South Korean Medical Regulation and Data Utilization
Recently, the World Health Organization (WHO) Regional Office for Europe and the Portuguese government jointly hosted an 'AI Healthcare' conference. The meeting featured in-depth discussions on the direction of advancements in disease diagnosis, treatment, and personalized medicine using artificial intelligence (AI).
In particular, the issue of 'data governance,' which refers to the secure management and utilization of medical data, was a key agenda item at this conference. As AI technology is rapidly introduced into medical settings, how to protect patients' sensitive information while achieving technological innovation has emerged as a global challenge.
While medical technology utilizing AI is also developing rapidly in South Korea, critics point out that strict medical regulations are slowing down the speed of technology adoption. Experts emphasize the need to review and improve South Korea's medical regulatory framework by referring to the cases discussed at this international conference.
In conclusion, AI healthcare is a core field of future medicine. For South Korea to secure global competitiveness, it is urgent to establish flexible policies that can revitalize data utilization while simultaneously protecting patient safety.